Diagnostic Value of Vessel Wall Imaging to Determine the Timing of Extracranial‒Intracranial Bypass for Moyamoya Syndrome Associated with Active Sjögren's Syndrome: A Case Report

Abstract

Background Sjögren's syndrome is a chronic autoimmune disorder that predominantly affects exocrine organs. It is characterized by an organ-specific infiltration of lymphocytes. The involvement of the major cerebral arteries in Sjögren's syndrome has rarely been reported. A recent study reported a case of successful extracranial–intracranial (EC–IC) bypass without complications, even in the active inflammatory state, although the optimal timing of such a bypass remains unclear.

Case Description We here report the case of a 43-year-old woman presenting with acute ischemic stroke due to progressive middle cerebral artery (MCA) occlusion and signs of primary Sjögren's syndrome. During intensive immunosuppressive therapy for active Sjögren's syndrome, the patient was monitored using contrast-enhanced magnetic resonance vessel wall imaging (MR-VWI). A couple of intravenous cyclophosphamide injections combined with a methylprednisolone pulse and antiplatelet therapy resulted in clear resolution of vessel wall enhancement, which suggested remission of inflammatory vasculitis. Nevertheless, she still experienced a transient ischemic attack (TIA) due to decreased regional cerebral blood flow by MCA occlusion, as demonstrated by the conventional time-of-flight MR angiography and single-photon emission computed tomography. Considering the increased risk of further stroke, the decision was made to perform an EC–IC bypass as a treatment for medically uncontrollable hemodynamic impairment. Her postoperative course was uneventful without further repeated TIAs, and continued immunosuppressive therapy for Sjögren's syndrome provided effective management.

Conclusions Our findings emphasize the diagnostic value of contrast-enhanced MR-VWI in monitoring the effect of immunosuppressive therapy for the major cerebral artery vasculitis and in determining the timing of EC–IC bypass as a “rescue” treatment for moyamoya syndrome associated with active Sjögren's syndrome.

Keywords

large cerebral artery - moyamoya syndrome - Sjögren's syndrome - vascular disorder - vessel wall imaging

Publication History

Received: 24 February 2022

Accepted: 19 April 2022

Accepted Manuscript online:
22 April 2022

Article published online:
23 May 2023

• References

• 1 Fox RI. Sjögren's syndrome. Lancet 2005; 366 (9482): 321-331
• 2 Chiang CH, Liu CJ, Chen PJ. et al. Primary Sjögren's syndrome and risk of ischemic stroke: a nationwide study. Clin Rheumatol 2014; 33 (07) 931-937
• 3 Nagahiro S, Mantani A, Yamada K, Ushio Y. Multiple cerebral arterial occlusions in a young patient with Sjögren's syndrome: case report. Neurosurgery 1996; 38 (03) 592-595 , discussion 595
• 4 Ii Y, Shindo A, Sasaki R, Naito Y, Tanaka K, Kuzuhara S. Reversible stenosis of large cerebral arteries in a patient with combined Sjögren's syndrome and neuromyelitis optica spectrum disorder. Rheumatol Int 2008; 28 (12) 1277-1280
• 5 Raja Shariff REF, Kasim S. Recurrent acute ischaemic strokes as the primary presentation of Sjögren's syndrome. Proc Singapore Healthc 2020; 29 (02) 142-144
• 6 Unnikrishnan G, Hiremath N, Chandrasekharan K, Sreedharan SE, Sylaja PN. Cerebral large-vessel vasculitis in Sjogren's syndrome: Utility of high-resolution magnetic resonance vessel wall imaging. J Clin Neurol 2018; 14 (04) 588-590
• 7 Matsuki Y, Kawakami M, Ishizuka T. et al. SLE and Sjögren's syndrome associated with unilateral moyamoya vessels in cerebral arteries. Scand J Rheumatol 1997; 26 (05) 392-394
• 8 Sakata H, Fujimura M, Sato K, Shimizu H, Tominaga T. Efficacy of extracranial-intracranial bypass for progressive middle cerebral artery occlusion associated with active Sjögren's syndrome: case report. J Stroke Cerebrovasc Dis 2014; 23 (08) e399-e402
• 9 Hasiloglu ZI, Albayram S, Tasmali K, Erer B, Selcuk H, Islak C. A case of primary Sjögren's syndrome presenting primarily with central nervous system vasculitic involvement. Rheumatol Int 2012; 32 (03) 805-807
• 10 Young CC, Bonow RH, Barros G, Mossa-Basha M, Kim LJ, Levitt MR. Magnetic resonance vessel wall imaging in cerebrovascular diseases. Neurosurg Focus 2019; 47 (06) E4
• 11 Fujimura M, Tominaga T, Kuroda S. et al; Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor Welfare, Japan, Guideline Committee 2021 of the Japan Stroke Society. 2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. Neurol Med Chir (Tokyo) 2022; 62 (04) 165-170
• 12 Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009; 360 (12) 1226-1237
• 13 Fujimura M, Bang OY, Kim JS. Moyamoya Disease. Front Neurol Neurosci 2016; 40: 204-220